Skip to content

Site Navigation

Exclusive Sponsored

PB Conference Learning Gallery

Search

Latest Stories

Start your day right!

Get the latest updates and insights delivered to your inbox

Enter your email

Exclusive Sponsored

PB Conference Learning Gallery

Advertise With Us Terms & Conditions Privacy Policy Cookie Policy Contact About Us Newsletter Subsciption Subscribe

Follow us

Home
influenza strains

influenza strains

AstraZeneca partners with CEPI to develop multi-specific influenza antibody

Getty Images

AstraZeneca secures £33M CEPI funding to develop multi-specific influenza antibody

Longjam Dineshwori

Mar 21, 2025

Recent

load more

Advertise With Us Terms & Conditions Privacy Policy Cookie Policy Contact About Us Newsletter Subsciption Subscribe

© Copyright 2025 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc